IFNB1 and myeloid sarcoma: In both mice with EAE and patients with MS, IFN-β also decreased the ability of dendritic cells to stimulate the production of IL-17 by Th17 cells and increased the production of IL-27 by dendritic cells, shifting the proinflammatory response into an anti-inflammatory one [76].